Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1871)
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Garfield Alastair — Chief Scientific Officer
Shares
800
Price
$119.17
Total Value
$95.34K
Shares Held After
2,295
% of Holdings
25.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Garfield Alastair — Chief Scientific Officer
Shares
3,400
Price
$118.28
Total Value
$402.17K
Shares Held After
3,095
% of Holdings
52.3%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Garfield Alastair — Chief Scientific Officer
Shares
1,556
Price
$117.08
Total Value
$182.17K
Shares Held After
6,495
% of Holdings
19.3%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Garfield Alastair — Chief Scientific Officer
Shares
2,007
Price
$116.11
Total Value
$233.03K
Shares Held After
8,051
% of Holdings
20.0%
VEEVA SYSTEMS INC (VEEV)
Schwenger Thomas D. — Pres.&Chief Customer Officer
Shares
1,819
Price
$251.03
Total Value
$456.62K
Shares Held After
19,449
% of Holdings
8.6%
VEEVA SYSTEMS INC (VEEV)
Schwenger Thomas D. — Pres.&Chief Customer Officer
Shares
33,181
Price
$250.44
Total Value
$8.31M
Shares Held After
21,268
% of Holdings
60.9%
VEEVA SYSTEMS INC (VEEV)
Schwenger Thomas D. — Pres.&Chief Customer Officer
Shares
1,000
Price
$241.91
Total Value
$241.91K
Shares Held After
19,449
% of Holdings
4.9%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP&CFO
Shares
1,772
Price
$59.14
Total Value
$104.80K
Shares Held After
0
% of Holdings
100.0%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP&CFO
Shares
9,230
Price
$58.59
Total Value
$540.75K
Shares Held After
1,772
% of Holdings
83.9%
Dyne Therapeutics, Inc. (DYN)
Lucera Erick — Chief Financial Officer
Shares
1,797
Price
$26.28
Total Value
$47.23K
Shares Held After
119,766
% of Holdings
1.5%
VERU INC. (VERU)
BARNETTE K GARY — Chief Scientific Officer
Shares
1,800
Price
$2.69
Total Value
$4.84K
Shares Held After
2,300
% of Holdings
78.3%
10x Genomics, Inc. (TXG)
Teichmann Sarah A. — Director
Shares
5,278
Price
$57.29
Total Value
$302.38K
Shares Held After
30,331
% of Holdings
14.8%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
4,986
Price
$26.28
Total Value
$131.03K
Shares Held After
363,165
% of Holdings
1.4%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
1,556
Price
$26.28
Total Value
$40.89K
Shares Held After
167,599
% of Holdings
0.9%
Aclarion, Inc. (ACON)
Neal David K — Director
Shares
7,500
Price
$2.40
Total Value
$18.00K
Shares Held After
30,002
% of Holdings
25.0%
Aclarion, Inc. (ACON)
Ness Brent — Director
Shares
5,234
Price
$2.31
Total Value
$12.09K
Shares Held After
111,534
% of Holdings
4.7%
Aclarion, Inc. (ACON)
Wesemann William — Director
Shares
2,150
Price
$2.34
Total Value
$5.03K
Shares Held After
23,713
% of Holdings
9.1%
Aclarion, Inc. (ACON)
Bond Ryan — Director
Shares
21,122
Price
$2.37
Total Value
$50.06K
Shares Held After
76,122
% of Holdings
27.7%
electroCore, Inc. (ECOR)
Errico Thomas J. — Director
Shares
5,000
Price
$9.85
Total Value
$49.27K
Shares Held After
343,332
% of Holdings
1.5%
Medpace Holdings, Inc. (MEDP)
Troendle August J. — Director
Shares
458
Price
$600.39
Total Value
$274.98K
Shares Held After
603,978
% of Holdings
0.1%
Amneal Pharmaceuticals, Inc. (AMRX)
Kiely John — Director
Shares
50,000
Price
$17.64
Total Value
$882.00K
Shares Held After
210,252
% of Holdings
19.2%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
4,000
Price
$7.52
Total Value
$30.08K
Shares Held After
586,887
% of Holdings
0.7%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
10,460
Price
$29.48
Total Value
$308.36K
Shares Held After
705,995
% of Holdings
1.5%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
2,375
Price
$28.11
Total Value
$66.76K
Shares Held After
716,455
% of Holdings
0.3%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
5,423
Price
$27.19
Total Value
$147.45K
Shares Held After
718,830
% of Holdings
0.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Lee Jennifer Kayden — EVP, Head of North America
Shares
75,834
Price
$117.38
Total Value
$8.90M
Shares Held After
0
% of Holdings
100.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,358
Price
$108.46
Total Value
$255.76K
Shares Held After
15,312
% of Holdings
13.3%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,142
Price
$107.71
Total Value
$230.72K
Shares Held After
17,670
% of Holdings
10.8%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
1,268
Price
$106.63
Total Value
$135.20K
Shares Held After
19,812
% of Holdings
6.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,132
Price
$105.57
Total Value
$225.08K
Shares Held After
21,080
% of Holdings
9.2%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,100
Price
$104.67
Total Value
$219.81K
Shares Held After
23,212
% of Holdings
8.3%
LifeStance Health Group, Inc. (LFST)
DeLuca Teresa — Director
Shares
20,441
Price
$12.23
Total Value
$249.99K
Shares Held After
104,593
% of Holdings
16.3%
BECTON DICKINSON&CO (BDX)
Polen Thomas E Jr — Director
Shares
4,152
Price
$185.00
Total Value
$768.12K
Shares Held After
110,163
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$512.36
Total Value
$122.97K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$511.12
Total Value
$81.78K
Shares Held After
324,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$509.92
Total Value
$101.98K
Shares Held After
324,843
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$508.76
Total Value
$325.61K
Shares Held After
325,043
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$507.14
Total Value
$466.57K
Shares Held After
325,683
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,679
Price
$506.16
Total Value
$849.84K
Shares Held After
326,603
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
961
Price
$505.18
Total Value
$485.48K
Shares Held After
328,282
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$503.83
Total Value
$80.61K
Shares Held After
329,243
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$502.93
Total Value
$221.29K
Shares Held After
329,403
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,519
Price
$501.88
Total Value
$762.35K
Shares Held After
329,843
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,328
Price
$500.93
Total Value
$665.24K
Shares Held After
331,362
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,253
Price
$500.08
Total Value
$626.60K
Shares Held After
332,690
% of Holdings
0.4%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
2,919
Price
$43.41
Total Value
$126.70K
Shares Held After
8,625
% of Holdings
25.3%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
16,142
Price
$27.61
Total Value
$445.62K
Shares Held After
0
% of Holdings
100.0%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
30,000
Price
$20.26
Total Value
$607.80K
Shares Held After
162,844
% of Holdings
15.6%
JOHNSON&JOHNSON (JNJ)
Duato Joaquin — Director
Shares
102,315
Price
$261.00
Total Value
$26.70M
Shares Held After
275,967
% of Holdings
27.0%
JOHNSON&JOHNSON (JNJ)
Duato Joaquin — Director
Shares
20,976
Price
$262.00
Total Value
$5.50M
Shares Held After
378,282
% of Holdings
5.3%
Showing 301–350 of 1871 transactions (page 7 of 38)